Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Shanghai Haohai Biological Technology Co Ltd (6826)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
42.55 +0.95    +2.28%
31/05 - Closed. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  CNE100001W69 
  • Volume: 270,200
  • Bid/Ask: 42.55 / 42.60
  • Day's Range: 42.35 - 43.45
Shanghai Haohai Biological Tech 42.55 +0.95 +2.28%

6826 Balance Sheet

 
Featured here, the Balance Sheet for Shanghai Haohai Biological Technology Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Collapse All
Period Ending: 2024
31/03
 2023
31/12
 2023
30/09
 2023
30/06
Total Current Assets 3745.33 3750.14 3715.8 3878.57
Cash and Short Term Investments 2726.67 2774.66 2669.89 2847.17
Cash - - - -
Cash & Equivalents 2677.45 - 2653.99 2829.83
Short Term Investments - 23.58 - 17.34
Total Receivables, Net 357.88 375.43 390.63 398.46
Accounts Receivables - Trade, Net 328.76 - 376.33 398.46
Total Inventory 533.64 - 565.14 537.88
Prepaid Expenses - - - -
Other Current Assets, Total 127.15 112.23 90.14 95.06
Total Assets 7192.95 7105.5 7089.43 7254.17
Property/Plant/Equipment, Total - Net 1525.69 1615.05 1445.01 1519.12
Property/Plant/Equipment, Total - Gross - 2214.8 - -
Accumulated Depreciation, Total - -630.02 - -
Goodwill, Net 412.91 - 412.25 413.31
Intangibles, Net 710.79 574.88 740.12 605.51
Long Term Investments 615.23 607.1 635.89 658.79
Note Receivable - Long Term 29.12 47.57 14.3 -
Other Long Term Assets, Total 121.55 - 73.39 118.8
Other Assets, Total 413.58 389.1 347.52 311.88
Total Current Liabilities 689.77 715.95 580.06 657.79
Accounts Payable 77.83 176.39 88.49 86.93
Payable/Accrued - - - -
Accrued Expenses 80.56 - 97.56 208.35
Notes Payable/Short Term Debt 10 10 10 10
Current Port. of LT Debt/Capital Leases 207.39 206.62 - 41.74
Other Current liabilities, Total 313.98 228.24 384.01 310.76
Total Liabilities 1070.72 1088.2 1011.07 1163.6
Total Long Term Debt 172.81 191.32 265.01 178.81
Long Term Debt 172.81 157.44 235.02 146.37
Capital Lease Obligations - - 29.99 32.44
Deferred Income Tax 157.35 161.66 155.5 161.59
Minority Interest 367.16 - 373.39 380.95
Other Liabilities, Total -326.37 -711.72 -563.45 -406.1
Total Equity 6122.23 6017.29 6078.36 6090.57
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 168.71 171.48 171.33 171.29
Additional Paid-In Capital 2903.61 2981.2 2961.09 2959.03
Retained Earnings (Accumulated Deficit) 2918.25 2817.55 2726.43 2604.86
Treasury Stock - Common -140.1 -248.46 -90.88 -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 271.77 295.52 310.39 355.39
Total Liabilities & Shareholders' Equity 7192.95 - 7089.43 7254.17
Total Common Shares Outstanding 168.18 29.6 170.83 32.9
Total Preferred Shares Outstanding - - - -
* In Millions of CNY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

5HB Comments

Write your thoughts about Shanghai Haohai Biological Technology Co Ltd
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
JAME Megueni
VRAQ Feb 03, 2022 10:55PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
*C Suisse Downgrades HAOHAI BIOTEC to Underperform with TP Cut to $45
Reply
1 0
Report
JAME Megueni
VRAQ Jan 05, 2022 5:21AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
C Suisse Chops HAOHAI BIOTEC TP to $60, Rated Outperform
Reply
0 0
Report
JAME Megueni
VRAQ May 30, 2021 10:18PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
HSBC Global Research Heightens HAOHAI BIOTEC TP to $99; Rated ***Buy***
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email